nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Sibutramine—obesity	0.111	0.27	CbGbCtD
Maraviroc—CYP3A4—Benzphetamine—obesity	0.0843	0.204	CbGbCtD
Maraviroc—CYP3A4—Bupropion—obesity	0.0717	0.174	CbGbCtD
Maraviroc—CYP3A4—Orlistat—obesity	0.0585	0.142	CbGbCtD
Maraviroc—CYP3A4—Cimetidine—obesity	0.0526	0.127	CbGbCtD
Maraviroc—CYP3A4—Topiramate—obesity	0.0345	0.0834	CbGbCtD
Maraviroc—CCR5—respiratory system—obesity	0.0129	0.323	CbGeAlD
Maraviroc—CCR5—cardiovascular system—obesity	0.0099	0.248	CbGeAlD
Maraviroc—CCR5—digestive system—obesity	0.00821	0.206	CbGeAlD
Maraviroc—CCR5—endocrine gland—obesity	0.00679	0.17	CbGeAlD
Maraviroc—CYP3A4—digestive system—obesity	0.000828	0.0207	CbGeAlD
Maraviroc—CYP3A4—endocrine gland—obesity	0.000685	0.0171	CbGeAlD
Maraviroc—CYP3A4—liver—obesity	0.000617	0.0155	CbGeAlD
Maraviroc—Nausea—Phenylpropanolamine—obesity	0.000451	0.00156	CcSEcCtD
Maraviroc—Pharyngitis—Sibutramine—obesity	0.000449	0.00156	CcSEcCtD
Maraviroc—Hypersensitivity—Cimetidine—obesity	0.000443	0.00154	CcSEcCtD
Maraviroc—Pneumonia—Bupropion—obesity	0.000442	0.00153	CcSEcCtD
Maraviroc—Infestation NOS—Bupropion—obesity	0.000439	0.00152	CcSEcCtD
Maraviroc—Infestation—Bupropion—obesity	0.000439	0.00152	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Bupropion—obesity	0.000436	0.00151	CcSEcCtD
Maraviroc—Acute coronary syndrome—Bupropion—obesity	0.000433	0.0015	CcSEcCtD
Maraviroc—Diarrhoea—Diethylpropion—obesity	0.000433	0.0015	CcSEcCtD
Maraviroc—Nausea—Phentermine—obesity	0.000432	0.0015	CcSEcCtD
Maraviroc—Asthenia—Cimetidine—obesity	0.000432	0.00149	CcSEcCtD
Maraviroc—Myocardial infarction—Bupropion—obesity	0.000431	0.00149	CcSEcCtD
Maraviroc—Neuropathy peripheral—Bupropion—obesity	0.000431	0.00149	CcSEcCtD
Maraviroc—Jaundice—Bupropion—obesity	0.000428	0.00148	CcSEcCtD
Maraviroc—Stomatitis—Bupropion—obesity	0.000428	0.00148	CcSEcCtD
Maraviroc—Conjunctivitis—Bupropion—obesity	0.000427	0.00148	CcSEcCtD
Maraviroc—Lymphadenopathy—Topiramate—obesity	0.000426	0.00147	CcSEcCtD
Maraviroc—Eye disorder—Sibutramine—obesity	0.000423	0.00146	CcSEcCtD
Maraviroc—Mediastinal disorder—Orlistat—obesity	0.000421	0.00146	CcSEcCtD
Maraviroc—Sleep disorder—Topiramate—obesity	0.00042	0.00145	CcSEcCtD
Maraviroc—Dizziness—Diethylpropion—obesity	0.000418	0.00145	CcSEcCtD
Maraviroc—Diabetes mellitus—Topiramate—obesity	0.000418	0.00145	CcSEcCtD
Maraviroc—Blood alkaline phosphatase increased—Topiramate—obesity	0.000418	0.00145	CcSEcCtD
Maraviroc—Polyuria—Topiramate—obesity	0.000414	0.00143	CcSEcCtD
Maraviroc—Alopecia—Orlistat—obesity	0.000413	0.00143	CcSEcCtD
Maraviroc—Sinusitis—Bupropion—obesity	0.000412	0.00143	CcSEcCtD
Maraviroc—Diarrhoea—Cimetidine—obesity	0.000412	0.00143	CcSEcCtD
Maraviroc—Angiopathy—Sibutramine—obesity	0.000411	0.00142	CcSEcCtD
Maraviroc—Mental disorder—Orlistat—obesity	0.00041	0.00142	CcSEcCtD
Maraviroc—Malnutrition—Orlistat—obesity	0.000407	0.00141	CcSEcCtD
Maraviroc—Deafness—Topiramate—obesity	0.000406	0.00141	CcSEcCtD
Maraviroc—Vascular purpura—Topiramate—obesity	0.000406	0.00141	CcSEcCtD
Maraviroc—Eczema—Topiramate—obesity	0.000404	0.0014	CcSEcCtD
Maraviroc—Hepatic failure—Topiramate—obesity	0.000404	0.0014	CcSEcCtD
Maraviroc—Vomiting—Diethylpropion—obesity	0.000402	0.00139	CcSEcCtD
Maraviroc—Flatulence—Orlistat—obesity	0.000401	0.00139	CcSEcCtD
Maraviroc—Alopecia—Sibutramine—obesity	0.0004	0.00138	CcSEcCtD
Maraviroc—Nasal congestion—Topiramate—obesity	0.000399	0.00138	CcSEcCtD
Maraviroc—Rash—Diethylpropion—obesity	0.000399	0.00138	CcSEcCtD
Maraviroc—Dermatitis—Diethylpropion—obesity	0.000398	0.00138	CcSEcCtD
Maraviroc—Dizziness—Cimetidine—obesity	0.000398	0.00138	CcSEcCtD
Maraviroc—Headache—Diethylpropion—obesity	0.000396	0.00137	CcSEcCtD
Maraviroc—Rhinitis—Bupropion—obesity	0.000395	0.00137	CcSEcCtD
Maraviroc—Malnutrition—Sibutramine—obesity	0.000394	0.00136	CcSEcCtD
Maraviroc—Hallucination—Bupropion—obesity	0.000392	0.00136	CcSEcCtD
Maraviroc—Pharyngitis—Bupropion—obesity	0.000391	0.00136	CcSEcCtD
Maraviroc—Urinary tract disorder—Bupropion—obesity	0.00039	0.00135	CcSEcCtD
Maraviroc—Flatulence—Sibutramine—obesity	0.000388	0.00134	CcSEcCtD
Maraviroc—Connective tissue disorder—Bupropion—obesity	0.000388	0.00134	CcSEcCtD
Maraviroc—Urethral disorder—Bupropion—obesity	0.000387	0.00134	CcSEcCtD
Maraviroc—Amnesia—Topiramate—obesity	0.000387	0.00134	CcSEcCtD
Maraviroc—Vomiting—Cimetidine—obesity	0.000383	0.00132	CcSEcCtD
Maraviroc—Rash—Cimetidine—obesity	0.000379	0.00131	CcSEcCtD
Maraviroc—Dermatitis—Cimetidine—obesity	0.000379	0.00131	CcSEcCtD
Maraviroc—Headache—Cimetidine—obesity	0.000377	0.00131	CcSEcCtD
Maraviroc—Purpura—Topiramate—obesity	0.000377	0.00131	CcSEcCtD
Maraviroc—Nausea—Diethylpropion—obesity	0.000376	0.0013	CcSEcCtD
Maraviroc—Erythema multiforme—Bupropion—obesity	0.000373	0.00129	CcSEcCtD
Maraviroc—Tremor—Sibutramine—obesity	0.000369	0.00128	CcSEcCtD
Maraviroc—Eye disorder—Bupropion—obesity	0.000369	0.00128	CcSEcCtD
Maraviroc—Cardiac disorder—Bupropion—obesity	0.000366	0.00127	CcSEcCtD
Maraviroc—Anaemia—Sibutramine—obesity	0.000364	0.00126	CcSEcCtD
Maraviroc—Angiopathy—Bupropion—obesity	0.000358	0.00124	CcSEcCtD
Maraviroc—Nausea—Cimetidine—obesity	0.000357	0.00124	CcSEcCtD
Maraviroc—Mediastinal disorder—Bupropion—obesity	0.000355	0.00123	CcSEcCtD
Maraviroc—Cough—Orlistat—obesity	0.000355	0.00123	CcSEcCtD
Maraviroc—Syncope—Sibutramine—obesity	0.000353	0.00122	CcSEcCtD
Maraviroc—Convulsion—Orlistat—obesity	0.000353	0.00122	CcSEcCtD
Maraviroc—Leukopenia—Sibutramine—obesity	0.000353	0.00122	CcSEcCtD
Maraviroc—Alopecia—Bupropion—obesity	0.000349	0.00121	CcSEcCtD
Maraviroc—Myalgia—Orlistat—obesity	0.000346	0.0012	CcSEcCtD
Maraviroc—Loss of consciousness—Sibutramine—obesity	0.000346	0.0012	CcSEcCtD
Maraviroc—Mental disorder—Bupropion—obesity	0.000346	0.0012	CcSEcCtD
Maraviroc—Anxiety—Orlistat—obesity	0.000345	0.0012	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000344	0.00119	CcSEcCtD
Maraviroc—Cough—Sibutramine—obesity	0.000344	0.00119	CcSEcCtD
Maraviroc—Malnutrition—Bupropion—obesity	0.000343	0.00119	CcSEcCtD
Maraviroc—Discomfort—Orlistat—obesity	0.000342	0.00119	CcSEcCtD
Maraviroc—Convulsion—Sibutramine—obesity	0.000341	0.00118	CcSEcCtD
Maraviroc—Flatulence—Bupropion—obesity	0.000338	0.00117	CcSEcCtD
Maraviroc—Myalgia—Sibutramine—obesity	0.000335	0.00116	CcSEcCtD
Maraviroc—Anxiety—Sibutramine—obesity	0.000334	0.00116	CcSEcCtD
Maraviroc—Oedema—Orlistat—obesity	0.000332	0.00115	CcSEcCtD
Maraviroc—Abdominal pain upper—Topiramate—obesity	0.000332	0.00115	CcSEcCtD
Maraviroc—Orthostatic hypotension—Topiramate—obesity	0.000332	0.00115	CcSEcCtD
Maraviroc—Discomfort—Sibutramine—obesity	0.000331	0.00115	CcSEcCtD
Maraviroc—Infection—Orlistat—obesity	0.00033	0.00114	CcSEcCtD
Maraviroc—Breast disorder—Topiramate—obesity	0.000328	0.00114	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Topiramate—obesity	0.000327	0.00113	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Topiramate—obesity	0.000327	0.00113	CcSEcCtD
Maraviroc—Nervous system disorder—Orlistat—obesity	0.000326	0.00113	CcSEcCtD
Maraviroc—Nasopharyngitis—Topiramate—obesity	0.000325	0.00112	CcSEcCtD
Maraviroc—Skin disorder—Orlistat—obesity	0.000323	0.00112	CcSEcCtD
Maraviroc—Tremor—Bupropion—obesity	0.000322	0.00111	CcSEcCtD
Maraviroc—Oedema—Sibutramine—obesity	0.000321	0.00111	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Topiramate—obesity	0.00032	0.00111	CcSEcCtD
Maraviroc—Infection—Sibutramine—obesity	0.000319	0.00111	CcSEcCtD
Maraviroc—Anaemia—Bupropion—obesity	0.000317	0.0011	CcSEcCtD
Maraviroc—Shock—Sibutramine—obesity	0.000316	0.0011	CcSEcCtD
Maraviroc—Abdominal distension—Topiramate—obesity	0.000316	0.00109	CcSEcCtD
Maraviroc—Skin disorder—Sibutramine—obesity	0.000312	0.00108	CcSEcCtD
Maraviroc—Eosinophilia—Topiramate—obesity	0.000311	0.00108	CcSEcCtD
Maraviroc—Syncope—Bupropion—obesity	0.000308	0.00107	CcSEcCtD
Maraviroc—Pancreatitis—Topiramate—obesity	0.000308	0.00107	CcSEcCtD
Maraviroc—Leukopenia—Bupropion—obesity	0.000307	0.00106	CcSEcCtD
Maraviroc—Anorexia—Sibutramine—obesity	0.000306	0.00106	CcSEcCtD
Maraviroc—Angina pectoris—Topiramate—obesity	0.000306	0.00106	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Orlistat—obesity	0.000303	0.00105	CcSEcCtD
Maraviroc—Bronchitis—Topiramate—obesity	0.000302	0.00105	CcSEcCtD
Maraviroc—Loss of consciousness—Bupropion—obesity	0.000302	0.00105	CcSEcCtD
Maraviroc—Insomnia—Orlistat—obesity	0.0003	0.00104	CcSEcCtD
Maraviroc—Cough—Bupropion—obesity	0.0003	0.00104	CcSEcCtD
Maraviroc—Paraesthesia—Orlistat—obesity	0.000298	0.00103	CcSEcCtD
Maraviroc—Pancytopenia—Topiramate—obesity	0.000298	0.00103	CcSEcCtD
Maraviroc—Convulsion—Bupropion—obesity	0.000298	0.00103	CcSEcCtD
Maraviroc—Neutropenia—Topiramate—obesity	0.000294	0.00102	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Sibutramine—obesity	0.000293	0.00101	CcSEcCtD
Maraviroc—Myalgia—Bupropion—obesity	0.000292	0.00101	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Topiramate—obesity	0.000292	0.00101	CcSEcCtD
Maraviroc—Anxiety—Bupropion—obesity	0.000291	0.00101	CcSEcCtD
Maraviroc—Insomnia—Sibutramine—obesity	0.000291	0.00101	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00029	0.00101	CcSEcCtD
Maraviroc—Discomfort—Bupropion—obesity	0.000289	0.001	CcSEcCtD
Maraviroc—Decreased appetite—Orlistat—obesity	0.000289	0.001	CcSEcCtD
Maraviroc—Paraesthesia—Sibutramine—obesity	0.000289	0.001	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Orlistat—obesity	0.000287	0.000993	CcSEcCtD
Maraviroc—Fatigue—Orlistat—obesity	0.000286	0.000992	CcSEcCtD
Maraviroc—Pain—Orlistat—obesity	0.000284	0.000984	CcSEcCtD
Maraviroc—Pneumonia—Topiramate—obesity	0.000282	0.000975	CcSEcCtD
Maraviroc—Oedema—Bupropion—obesity	0.00028	0.00097	CcSEcCtD
Maraviroc—Infestation NOS—Topiramate—obesity	0.00028	0.000969	CcSEcCtD
Maraviroc—Infestation—Topiramate—obesity	0.00028	0.000969	CcSEcCtD
Maraviroc—Decreased appetite—Sibutramine—obesity	0.000279	0.000968	CcSEcCtD
Maraviroc—Depression—Topiramate—obesity	0.000279	0.000967	CcSEcCtD
Maraviroc—Infection—Bupropion—obesity	0.000278	0.000964	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Topiramate—obesity	0.000278	0.000961	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Sibutramine—obesity	0.000278	0.000961	CcSEcCtD
Maraviroc—Shock—Bupropion—obesity	0.000276	0.000955	CcSEcCtD
Maraviroc—Renal failure—Topiramate—obesity	0.000275	0.000953	CcSEcCtD
Maraviroc—Pain—Sibutramine—obesity	0.000275	0.000952	CcSEcCtD
Maraviroc—Constipation—Sibutramine—obesity	0.000275	0.000952	CcSEcCtD
Maraviroc—Nervous system disorder—Bupropion—obesity	0.000275	0.000952	CcSEcCtD
Maraviroc—Neuropathy peripheral—Topiramate—obesity	0.000274	0.00095	CcSEcCtD
Maraviroc—Stomatitis—Topiramate—obesity	0.000273	0.000945	CcSEcCtD
Maraviroc—Skin disorder—Bupropion—obesity	0.000272	0.000943	CcSEcCtD
Maraviroc—Conjunctivitis—Topiramate—obesity	0.000272	0.000942	CcSEcCtD
Maraviroc—Gastrointestinal pain—Orlistat—obesity	0.000272	0.000941	CcSEcCtD
Maraviroc—Anorexia—Bupropion—obesity	0.000267	0.000925	CcSEcCtD
Maraviroc—Gastrointestinal pain—Sibutramine—obesity	0.000263	0.00091	CcSEcCtD
Maraviroc—Sinusitis—Topiramate—obesity	0.000263	0.00091	CcSEcCtD
Maraviroc—Abdominal pain—Orlistat—obesity	0.000263	0.000909	CcSEcCtD
Maraviroc—Body temperature increased—Orlistat—obesity	0.000263	0.000909	CcSEcCtD
Maraviroc—Agranulocytosis—Topiramate—obesity	0.000261	0.000905	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Bupropion—obesity	0.000255	0.000884	CcSEcCtD
Maraviroc—Abdominal pain—Sibutramine—obesity	0.000254	0.00088	CcSEcCtD
Maraviroc—Body temperature increased—Sibutramine—obesity	0.000254	0.00088	CcSEcCtD
Maraviroc—Insomnia—Bupropion—obesity	0.000253	0.000878	CcSEcCtD
Maraviroc—Rhinitis—Topiramate—obesity	0.000252	0.000872	CcSEcCtD
Maraviroc—Paraesthesia—Bupropion—obesity	0.000252	0.000871	CcSEcCtD
Maraviroc—Hallucination—Topiramate—obesity	0.00025	0.000866	CcSEcCtD
Maraviroc—Pharyngitis—Topiramate—obesity	0.000249	0.000864	CcSEcCtD
Maraviroc—Urinary tract disorder—Topiramate—obesity	0.000248	0.000859	CcSEcCtD
Maraviroc—Connective tissue disorder—Topiramate—obesity	0.000247	0.000855	CcSEcCtD
Maraviroc—Urethral disorder—Topiramate—obesity	0.000246	0.000853	CcSEcCtD
Maraviroc—Hypersensitivity—Orlistat—obesity	0.000245	0.000847	CcSEcCtD
Maraviroc—Decreased appetite—Bupropion—obesity	0.000244	0.000844	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Bupropion—obesity	0.000242	0.000838	CcSEcCtD
Maraviroc—Fatigue—Bupropion—obesity	0.000242	0.000837	CcSEcCtD
Maraviroc—Pain—Bupropion—obesity	0.00024	0.00083	CcSEcCtD
Maraviroc—Constipation—Bupropion—obesity	0.00024	0.00083	CcSEcCtD
Maraviroc—Asthenia—Orlistat—obesity	0.000238	0.000825	CcSEcCtD
Maraviroc—Erythema multiforme—Topiramate—obesity	0.000238	0.000823	CcSEcCtD
Maraviroc—Hypersensitivity—Sibutramine—obesity	0.000237	0.00082	CcSEcCtD
Maraviroc—Pruritus—Orlistat—obesity	0.000235	0.000814	CcSEcCtD
Maraviroc—Eye disorder—Topiramate—obesity	0.000235	0.000813	CcSEcCtD
Maraviroc—Cardiac disorder—Topiramate—obesity	0.000233	0.000808	CcSEcCtD
Maraviroc—Asthenia—Sibutramine—obesity	0.000231	0.000799	CcSEcCtD
Maraviroc—Gastrointestinal pain—Bupropion—obesity	0.000229	0.000794	CcSEcCtD
Maraviroc—Angiopathy—Topiramate—obesity	0.000228	0.00079	CcSEcCtD
Maraviroc—Pruritus—Sibutramine—obesity	0.000227	0.000788	CcSEcCtD
Maraviroc—Diarrhoea—Orlistat—obesity	0.000227	0.000787	CcSEcCtD
Maraviroc—Mediastinal disorder—Topiramate—obesity	0.000226	0.000784	CcSEcCtD
Maraviroc—Alopecia—Topiramate—obesity	0.000222	0.000769	CcSEcCtD
Maraviroc—Abdominal pain—Bupropion—obesity	0.000222	0.000767	CcSEcCtD
Maraviroc—Body temperature increased—Bupropion—obesity	0.000222	0.000767	CcSEcCtD
Maraviroc—Mental disorder—Topiramate—obesity	0.00022	0.000762	CcSEcCtD
Maraviroc—Diarrhoea—Sibutramine—obesity	0.00022	0.000762	CcSEcCtD
Maraviroc—Dizziness—Orlistat—obesity	0.00022	0.000761	CcSEcCtD
Maraviroc—Erythema—Topiramate—obesity	0.000219	0.000758	CcSEcCtD
Maraviroc—Malnutrition—Topiramate—obesity	0.000219	0.000758	CcSEcCtD
Maraviroc—Flatulence—Topiramate—obesity	0.000216	0.000747	CcSEcCtD
Maraviroc—Dizziness—Sibutramine—obesity	0.000213	0.000736	CcSEcCtD
Maraviroc—Vomiting—Orlistat—obesity	0.000211	0.000731	CcSEcCtD
Maraviroc—Rash—Orlistat—obesity	0.000209	0.000725	CcSEcCtD
Maraviroc—Dermatitis—Orlistat—obesity	0.000209	0.000725	CcSEcCtD
Maraviroc—Headache—Orlistat—obesity	0.000208	0.000721	CcSEcCtD
Maraviroc—Hypersensitivity—Bupropion—obesity	0.000206	0.000715	CcSEcCtD
Maraviroc—Tremor—Topiramate—obesity	0.000205	0.00071	CcSEcCtD
Maraviroc—Vomiting—Sibutramine—obesity	0.000204	0.000708	CcSEcCtD
Maraviroc—Rash—Sibutramine—obesity	0.000203	0.000702	CcSEcCtD
Maraviroc—Dermatitis—Sibutramine—obesity	0.000202	0.000701	CcSEcCtD
Maraviroc—Anaemia—Topiramate—obesity	0.000202	0.0007	CcSEcCtD
Maraviroc—Headache—Sibutramine—obesity	0.000201	0.000697	CcSEcCtD
Maraviroc—Asthenia—Bupropion—obesity	0.000201	0.000696	CcSEcCtD
Maraviroc—Pruritus—Bupropion—obesity	0.000198	0.000687	CcSEcCtD
Maraviroc—Nausea—Orlistat—obesity	0.000197	0.000683	CcSEcCtD
Maraviroc—Syncope—Topiramate—obesity	0.000196	0.000679	CcSEcCtD
Maraviroc—Leukopenia—Topiramate—obesity	0.000196	0.000678	CcSEcCtD
Maraviroc—Loss of consciousness—Topiramate—obesity	0.000192	0.000666	CcSEcCtD
Maraviroc—Diarrhoea—Bupropion—obesity	0.000192	0.000664	CcSEcCtD
Maraviroc—Nausea—Sibutramine—obesity	0.000191	0.000661	CcSEcCtD
Maraviroc—Cough—Topiramate—obesity	0.000191	0.000661	CcSEcCtD
Maraviroc—Convulsion—Topiramate—obesity	0.00019	0.000656	CcSEcCtD
Maraviroc—Myalgia—Topiramate—obesity	0.000186	0.000645	CcSEcCtD
Maraviroc—Anxiety—Topiramate—obesity	0.000186	0.000643	CcSEcCtD
Maraviroc—Dizziness—Bupropion—obesity	0.000185	0.000642	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000185	0.000641	CcSEcCtD
Maraviroc—Discomfort—Topiramate—obesity	0.000184	0.000637	CcSEcCtD
Maraviroc—Oedema—Topiramate—obesity	0.000179	0.000618	CcSEcCtD
Maraviroc—Vomiting—Bupropion—obesity	0.000178	0.000617	CcSEcCtD
Maraviroc—Infection—Topiramate—obesity	0.000177	0.000614	CcSEcCtD
Maraviroc—Rash—Bupropion—obesity	0.000177	0.000612	CcSEcCtD
Maraviroc—Dermatitis—Bupropion—obesity	0.000177	0.000611	CcSEcCtD
Maraviroc—Shock—Topiramate—obesity	0.000176	0.000608	CcSEcCtD
Maraviroc—Headache—Bupropion—obesity	0.000176	0.000608	CcSEcCtD
Maraviroc—Nervous system disorder—Topiramate—obesity	0.000175	0.000606	CcSEcCtD
Maraviroc—Skin disorder—Topiramate—obesity	0.000173	0.000601	CcSEcCtD
Maraviroc—Anorexia—Topiramate—obesity	0.00017	0.000589	CcSEcCtD
Maraviroc—Nausea—Bupropion—obesity	0.000166	0.000576	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Topiramate—obesity	0.000163	0.000563	CcSEcCtD
Maraviroc—Insomnia—Topiramate—obesity	0.000161	0.000559	CcSEcCtD
Maraviroc—Paraesthesia—Topiramate—obesity	0.00016	0.000555	CcSEcCtD
Maraviroc—Decreased appetite—Topiramate—obesity	0.000155	0.000537	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Topiramate—obesity	0.000154	0.000534	CcSEcCtD
Maraviroc—Fatigue—Topiramate—obesity	0.000154	0.000533	CcSEcCtD
Maraviroc—Constipation—Topiramate—obesity	0.000153	0.000529	CcSEcCtD
Maraviroc—Pain—Topiramate—obesity	0.000153	0.000529	CcSEcCtD
Maraviroc—Gastrointestinal pain—Topiramate—obesity	0.000146	0.000506	CcSEcCtD
Maraviroc—Body temperature increased—Topiramate—obesity	0.000141	0.000489	CcSEcCtD
Maraviroc—Abdominal pain—Topiramate—obesity	0.000141	0.000489	CcSEcCtD
Maraviroc—Hypersensitivity—Topiramate—obesity	0.000132	0.000456	CcSEcCtD
Maraviroc—Asthenia—Topiramate—obesity	0.000128	0.000444	CcSEcCtD
Maraviroc—Pruritus—Topiramate—obesity	0.000126	0.000437	CcSEcCtD
Maraviroc—Diarrhoea—Topiramate—obesity	0.000122	0.000423	CcSEcCtD
Maraviroc—Dizziness—Topiramate—obesity	0.000118	0.000409	CcSEcCtD
Maraviroc—Vomiting—Topiramate—obesity	0.000114	0.000393	CcSEcCtD
Maraviroc—Rash—Topiramate—obesity	0.000113	0.00039	CcSEcCtD
Maraviroc—Dermatitis—Topiramate—obesity	0.000112	0.000389	CcSEcCtD
Maraviroc—Headache—Topiramate—obesity	0.000112	0.000387	CcSEcCtD
Maraviroc—CCR5—Disease—FOXO1—obesity	0.000111	0.000428	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CG—obesity	0.00011	0.000426	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	0.000109	0.000422	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PARP1—obesity	0.000109	0.00042	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GHRL—obesity	0.000109	0.00042	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000109	0.00042	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD4—obesity	0.000108	0.000417	CbGpPWpGaD
Maraviroc—Nausea—Topiramate—obesity	0.000106	0.000367	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—POMC—obesity	0.000105	0.000405	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—F2—obesity	0.000104	0.000404	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PRKCB—obesity	0.000104	0.000404	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CNR1—obesity	0.000103	0.000398	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	0.000103	0.000398	CbGpPWpGaD
Maraviroc—CCR5—Disease—PRKCD—obesity	0.000103	0.000397	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TCF7L2—obesity	0.000101	0.000391	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT2—obesity	0.000101	0.000389	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DRD2—obesity	0.0001	0.000388	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTHFR—obesity	0.0001	0.000388	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CG—obesity	9.99e-05	0.000386	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GCG—obesity	9.94e-05	0.000385	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTPN1—obesity	9.94e-05	0.000385	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—ADH1B—obesity	9.7e-05	0.000375	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CD—obesity	9.67e-05	0.000374	CbGpPWpGaD
Maraviroc—CCR5—Disease—IRS2—obesity	9.54e-05	0.000369	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—POMC—obesity	9.5e-05	0.000368	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRL—obesity	9.48e-05	0.000367	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STK11—obesity	9.34e-05	0.000362	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—obesity	9.33e-05	0.000361	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	9.3e-05	0.00036	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL2—obesity	9.3e-05	0.00036	CbGpPWpGaD
Maraviroc—CCR5—Disease—CAV1—obesity	9.25e-05	0.000358	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLG—obesity	9.24e-05	0.000358	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOA1—obesity	9.23e-05	0.000357	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—RHOA—obesity	9.22e-05	0.000357	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	9.17e-05	0.000355	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT2—obesity	9.14e-05	0.000354	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3R1—obesity	9.13e-05	0.000353	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FOXO3—obesity	9.02e-05	0.000349	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRB2—obesity	8.99e-05	0.000348	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SOCS1—obesity	8.86e-05	0.000343	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CD—obesity	8.78e-05	0.00034	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SOCS3—obesity	8.75e-05	0.000339	CbGpPWpGaD
Maraviroc—CCR5—Disease—BAD—obesity	8.7e-05	0.000337	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNB3—obesity	8.56e-05	0.000331	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—TYK2—obesity	8.44e-05	0.000327	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CB—obesity	8.43e-05	0.000326	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF2—obesity	8.41e-05	0.000326	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—RHOA—obesity	8.38e-05	0.000324	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNAS—obesity	8.34e-05	0.000323	CbGpPWpGaD
Maraviroc—CCR5—Disease—IRS1—obesity	8.33e-05	0.000322	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3R1—obesity	8.29e-05	0.000321	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOB—obesity	8.17e-05	0.000316	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL5—obesity	7.97e-05	0.000309	CbGpPWpGaD
Maraviroc—CCR5—Disease—INS—obesity	7.97e-05	0.000309	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LPL—obesity	7.8e-05	0.000302	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FOXO1—obesity	7.74e-05	0.0003	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RPS6KB1—obesity	7.73e-05	0.000299	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT2—obesity	7.71e-05	0.000298	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CB—obesity	7.65e-05	0.000296	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—SULT2A1—obesity	7.47e-05	0.000289	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3CD—obesity	7.41e-05	0.000287	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	7.37e-05	0.000285	CbGpPWpGaD
Maraviroc—CCR5—Disease—SERPINE1—obesity	7.32e-05	0.000283	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCD—obesity	7.18e-05	0.000278	CbGpPWpGaD
Maraviroc—CCR5—Disease—TYK2—obesity	7.12e-05	0.000276	CbGpPWpGaD
Maraviroc—CCR5—Disease—RHOA—obesity	7.07e-05	0.000273	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GPX3—obesity	7.03e-05	0.000272	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—obesity	7.03e-05	0.000272	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—obesity	7.02e-05	0.000272	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3R1—obesity	6.99e-05	0.000271	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS3—obesity	6.99e-05	0.000271	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	6.8e-05	0.000263	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IRS2—obesity	6.68e-05	0.000258	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGT—obesity	6.67e-05	0.000258	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—obesity	6.54e-05	0.000253	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOE—obesity	6.54e-05	0.000253	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CAV1—obesity	6.48e-05	0.000251	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOA1—obesity	6.46e-05	0.00025	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTOR—obesity	6.45e-05	0.00025	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3CB—obesity	6.45e-05	0.00025	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—obesity	6.4e-05	0.000247	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ESR1—obesity	6.24e-05	0.000241	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	6.16e-05	0.000239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—F2—obesity	6.16e-05	0.000239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PRKCB—obesity	6.16e-05	0.000239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BAD—obesity	6.09e-05	0.000236	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CG—obesity	5.9e-05	0.000228	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IRS1—obesity	5.83e-05	0.000226	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—POMC—obesity	5.61e-05	0.000217	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—INS—obesity	5.58e-05	0.000216	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	5.51e-05	0.000213	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—obesity	5.49e-05	0.000213	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2E1—obesity	5.46e-05	0.000211	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1—obesity	5.4e-05	0.000209	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT2—obesity	5.4e-05	0.000209	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	5.39e-05	0.000209	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CD—obesity	5.19e-05	0.000201	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CA—obesity	5.14e-05	0.000199	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—obesity	5.13e-05	0.000198	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT1—obesity	5.02e-05	0.000194	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TYK2—obesity	4.99e-05	0.000193	CbGpPWpGaD
Maraviroc—CCR5—Disease—STAT3—obesity	4.99e-05	0.000193	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RHOA—obesity	4.95e-05	0.000191	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—NCOA1—obesity	4.94e-05	0.000191	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3R1—obesity	4.9e-05	0.000189	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOS3—obesity	4.9e-05	0.000189	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP19A1—obesity	4.87e-05	0.000188	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	4.8e-05	0.000186	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CA—obesity	4.66e-05	0.000181	CbGpPWpGaD
Maraviroc—CCR5—Disease—MYC—obesity	4.64e-05	0.000179	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—obesity	4.62e-05	0.000179	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA3—obesity	4.56e-05	0.000176	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—COMT—obesity	4.53e-05	0.000175	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MTOR—obesity	4.52e-05	0.000175	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CB—obesity	4.52e-05	0.000175	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—COMT—obesity	4.47e-05	0.000173	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—obesity	4.2e-05	0.000162	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—obesity	4.13e-05	0.00016	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3CA—obesity	3.93e-05	0.000152	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—obesity	3.93e-05	0.000152	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLRX—obesity	3.87e-05	0.00015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK8—obesity	3.82e-05	0.000148	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—obesity	3.81e-05	0.000147	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT3—obesity	3.49e-05	0.000135	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—obesity	3.48e-05	0.000135	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INSIG2—obesity	3.45e-05	0.000134	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPM1L—obesity	3.45e-05	0.000134	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—OTC—obesity	3.45e-05	0.000134	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ETFDH—obesity	3.45e-05	0.000134	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MYC—obesity	3.25e-05	0.000126	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—obesity	3.24e-05	0.000125	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—obesity	3.21e-05	0.000124	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPT—obesity	3.16e-05	0.000122	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UQCRC2—obesity	3.16e-05	0.000122	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INPP5E—obesity	3.16e-05	0.000122	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ME1—obesity	2.94e-05	0.000114	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH6A1—obesity	2.94e-05	0.000114	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SUCLG2—obesity	2.94e-05	0.000114	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—obesity	2.93e-05	0.000113	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UCP1—obesity	2.76e-05	0.000107	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COX7C—obesity	2.76e-05	0.000107	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNPLA3—obesity	2.76e-05	0.000107	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CA—obesity	2.76e-05	0.000107	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CS—obesity	2.62e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DGAT2—obesity	2.62e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CPS1—obesity	2.62e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SUCLA2—obesity	2.62e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MUT—obesity	2.5e-05	9.66e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LIPE—obesity	2.5e-05	9.66e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—obesity	2.44e-05	9.44e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DGAT1—obesity	2.39e-05	9.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYB5A—obesity	2.39e-05	9.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACLY—obesity	2.3e-05	8.92e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—obesity	2.25e-05	8.71e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALOX12—obesity	2.22e-05	8.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENPP1—obesity	2.22e-05	8.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMGCS1—obesity	2.15e-05	8.34e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNPLA2—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PFKFB3—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ANGPTL4—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACADM—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLIN1—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SAT1—obesity	2.09e-05	8.1e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—OXCT1—obesity	2.03e-05	7.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYTB—obesity	2.03e-05	7.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACACB—obesity	2.03e-05	7.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SRD5A1—obesity	1.98e-05	7.67e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNLIP—obesity	1.98e-05	7.67e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SDC3—obesity	1.94e-05	7.49e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HK2—obesity	1.89e-05	7.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—STS—obesity	1.89e-05	7.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP26B1—obesity	1.89e-05	7.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARD—obesity	1.85e-05	7.16e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC27A1—obesity	1.81e-05	7.02e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FABP4—obesity	1.78e-05	6.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLUL—obesity	1.78e-05	6.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UCP3—obesity	1.69e-05	6.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ECHS1—obesity	1.69e-05	6.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD11B1—obesity	1.69e-05	6.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UCP2—obesity	1.69e-05	6.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADH1B—obesity	1.66e-05	6.42e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPAM—obesity	1.63e-05	6.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1B—obesity	1.63e-05	6.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACSL1—obesity	1.63e-05	6.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PCK1—obesity	1.59e-05	6.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HADH—obesity	1.59e-05	6.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FADS1—obesity	1.59e-05	6.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACP5—obesity	1.54e-05	5.97e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—G6PD—obesity	1.5e-05	5.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SREBF2—obesity	1.48e-05	5.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HK1—obesity	1.48e-05	5.74e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPA—obesity	1.43e-05	5.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPIN1—obesity	1.4e-05	5.43e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA5—obesity	1.37e-05	5.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC22A1—obesity	1.31e-05	5.07e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CLOCK—obesity	1.31e-05	5.07e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SULT2A1—obesity	1.28e-05	4.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLP1R—obesity	1.28e-05	4.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DPYD—obesity	1.26e-05	4.87e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PRKAR2B—obesity	1.21e-05	4.68e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DCN—obesity	1.2e-05	4.65e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CPT1A—obesity	1.17e-05	4.52e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NAMPT—obesity	1.15e-05	4.44e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LIPC—obesity	1.14e-05	4.41e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCK—obesity	1.14e-05	4.41e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOC3—obesity	1.13e-05	4.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CETP—obesity	1.1e-05	4.25e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SDC1—obesity	1.09e-05	4.2e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKR1C3—obesity	1.07e-05	4.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SCARB1—obesity	1.05e-05	4.07e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SREBF1—obesity	1.02e-05	3.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—obesity	9.94e-06	3.85e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FASN—obesity	9.73e-06	3.76e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BCHE—obesity	9.68e-06	3.75e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2E1—obesity	9.34e-06	3.62e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NQO1—obesity	9.24e-06	3.58e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC2A4—obesity	8.86e-06	3.43e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCG—obesity	8.86e-06	3.43e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYCS—obesity	8.74e-06	3.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—obesity	8.58e-06	3.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT1—obesity	8.58e-06	3.32e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NCOA1—obesity	8.45e-06	3.27e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—STK11—obesity	8.33e-06	3.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP19A1—obesity	8.33e-06	3.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COMT—obesity	7.74e-06	3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GNB3—obesity	7.63e-06	2.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1A—obesity	7.63e-06	2.95e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—obesity	7.6e-06	2.94e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GNAS—obesity	7.43e-06	2.88e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOB—obesity	7.28e-06	2.82e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPL—obesity	6.95e-06	2.69e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—obesity	6.78e-06	2.62e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CD36—obesity	6.6e-06	2.56e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—obesity	6.26e-06	2.42e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARA—obesity	6.14e-06	2.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AGT—obesity	5.95e-06	2.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—obesity	5.83e-06	2.25e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAV1—obesity	5.77e-06	2.23e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA1—obesity	5.76e-06	2.23e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CG—obesity	5.26e-06	2.03e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—obesity	5.07e-06	1.96e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—obesity	5.01e-06	1.94e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—INS—obesity	4.98e-06	1.93e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CD—obesity	4.62e-06	1.79e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—obesity	4.56e-06	1.77e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—obesity	4.36e-06	1.69e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3R1—obesity	4.36e-06	1.69e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CB—obesity	4.03e-06	1.56e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—obesity	3.99e-06	1.54e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CA—obesity	2.46e-06	9.5e-06	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—obesity	2.01e-06	7.76e-06	CbGpPWpGaD
